Fierce Drug Dev Forum 2019 has ended
avatar for Laura Saltonstall, M.D., MBA

Laura Saltonstall, M.D., MBA

Vice President, US and LATAM Medical Affairs
Laura is Vice President, U.S. & LATAM Medical Affairs at Alnyalm where she is responsible for leading the U.S. and LATAM Medical Affairs organization across all therapeutic areas. Prior to joining Alnylam, Laura spent 14 years at Sanofi Genzyme where she was most recently Vice President, Head of Multiple Sclerosis Medical Affairs in North America. Earlier at Sanofi, she led the US LEMTRADA Medical Directors team and established the Multiple Sclerosis global scientific communications team. In these roles, she helped launch two therapies for multiple sclerosis, AUBAGIO and LEMTRADA. Prior to her tenure in medical affairs, Laura worked in oncology business development, program management, strategy as well as marketing in roles of increasing responsibility. Laura received her MD from Harvard Medical School and her MBA from MIT’s Sloan School of Management. She trained for two years as an OB-GYN at the Brigham and Women’s Hospital and Massachusetts General Hospital.  Laura serves on the board of trustees for Vincent Memorial Hospital, The Boston Home and the Massachusetts Eye and Ear Infirmary.